TMCnet News
Global Uterine Cancer Therapeutics & Diagnostics Market - Upsurge in Awareness About Uterine Diseases - Research and MarketsResearch and Markets has announced the addition of the "Global Uterine cancer therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)" report to their offering. Uterine cancer is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, around 47,130 new cases of endometrial cancer were diagnosed, and 8,010 women died from it in 2012. The Global Uterine Cancer Market is expected to grow modestly from USD 19,500 million in 2015, at a CAGR of 2-6%. Scope of the Report: The global uterine cancer therapeutics & diagnostic market is segmented based on: Type:
Treatment:
Major tests:
According to the surveys by WHO, incidences of endometrial cancer is greater in the developed regions such as the North American countries followed by the European nations due to the shifting lifestyle of women. Pervasiveness of uterine cancer is more in women aged 50 years and above. Drivers:
Restraints:
Companies Mentioned:
Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. Porters Five Force Analysis 5. Market Segmentation 6. Competitive Landscape 7. Company Profiles 8. Appendix For more information visit http://www.researchandmarkets.com/research/798x7d/global_uterine View source version on businesswire.com: http://www.businesswire.com/news/home/20160722005591/en/ |